Prospective Study of Bone Augmentation With Lateral Sinus Lift and Osseointegration of Dental Implants
Launched by MARIA H. PHAM · Jun 2, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a dental procedure called a lateral sinus lift, which helps prepare the upper jaw for dental implants when there isn't enough bone. In this study, researchers will compare two methods of bone augmentation: one side of the jaw will receive a treatment using a bone material from another source (called xenograft), while the other side will use the patient's own bone along with a special membrane (PRF). The goal is to understand which method is more effective and to ensure that the study results are reliable.
To participate in this trial, individuals should be over 18 years old and have lost at least two teeth in the back upper jaw, with enough bone height to support the procedure. Participants should also have good overall health without serious medical conditions that could slow healing, such as uncontrolled diabetes. The study is not yet recruiting participants, but if you qualify, you can expect to have both sides of your jaw treated in a similar way, allowing researchers to closely compare the outcomes. This trial aims to improve dental implant procedures for people with certain types of tooth loss.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Partially edentulous jaws in the lateral segment with 2 or more nearby lost teeth in the posterior upper jaw (maxilla), where the vertical height is a minimum of 2mm
- • absence of marginal periodontal disease
- • patients in American Society of Anesthesiologists ASA group 1-2 over 18 years.
- Exclusion Criteria:
- • ASA group 3 and above
- • ongoing infection
- • bruxism or abnormal habit
- • poor oral hygiene
- • medical conditions that may compromise healing (uncontrolled diabetes etc)
- • treatments that interfere with healing in the jaw bone (bisphosphonate, steroid therapy) radiotherapy or chemotherapy within the last 5 years
- • alcohol or substance abuse
- • heavy smoking
- • pregnancy
- • desire not to participate
About Maria H. Pham
Maria H. Pham is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in overseeing clinical studies, she specializes in the design, implementation, and management of trials across various therapeutic areas. Her approach emphasizes rigorous adherence to regulatory standards and ethical considerations, ensuring the integrity and reliability of trial results. Maria is passionate about fostering collaboration among stakeholders, including researchers, healthcare professionals, and participants, to drive innovation and contribute to the development of effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported